PuraPharm Corporation Limited (HKG:1498)
Hong Kong · Delayed Price · Currency is HKD 0.2800
0.00 (0.00%)
Aug 27, 2026, 4:08 PM HKT
PuraPharm Corporation Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 150 | 190 | 217 | 356 | 506 | 319 | |
Market Cap Growth | -18.45% | -12.58% | -38.89% | -29.69% | 58.47% | 19.41% |
Enterprise Value | 508 | 548 | 579 | 734 | 886 | 732 |
Last Close Price | 0.28 | 0.35 | 0.55 | 0.90 | 1.28 | 0.81 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 13.33 | 13.33 | 13.33 | 13.33 | 13.33 |
PS Ratio | 0.46 | 0.56 | 0.57 | 0.87 | 1.13 | 0.48 |
PB Ratio | 1.20 | 1.46 | 1.95 | 2.32 | 1.96 | 0.80 |
P/TBV Ratio | 3.59 | 4.17 | 3.52 | 3.54 | 2.53 | 0.94 |
P/FCF Ratio | - | 6.73 | 2.44 | 5.88 | 7.47 | - |
P/OCF Ratio | - | 6.66 | 2.09 | 4.47 | 5.71 | - |
PEG Ratio | - | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.57 | 1.63 | 1.52 | 1.80 | 1.98 | 1.11 |
EV/EBITDA Ratio | 16.74 | 87.93 | 37.96 | - | - | 18.24 |
EV/EBIT Ratio | - | - | - | - | - | 48.34 |
EV/FCF Ratio | - | 19.39 | 6.49 | 12.14 | 13.10 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 2.97 | 2.69 | 3.27 | 2.77 | 1.95 | 1.33 |
Debt / EBITDA Ratio | 12.12 | 14.03 | 10.62 | - | - | 8.53 |
Debt / FCF Ratio | - | 12.43 | 4.08 | 7.03 | 7.44 | - |
Net Debt / Equity Ratio | 2.87 | 2.42 | 2.94 | 2.49 | 1.59 | 1.09 |
Net Debt / EBITDA Ratio | 40.65 | 50.62 | 21.44 | -13.10 | -9.78 | 10.87 |
Net Debt / FCF Ratio | -55.35 | 11.16 | 3.67 | 6.32 | 6.09 | -24.75 |
Asset Turnover | 0.47 | 0.48 | 0.49 | 0.44 | 0.40 | 0.51 |
Inventory Turnover | 1.52 | 1.40 | 1.18 | 1.04 | 0.95 | 1.21 |
Quick Ratio | 0.12 | 0.20 | 0.21 | 0.23 | 0.35 | 0.54 |
Current Ratio | 0.46 | 0.47 | 0.55 | 0.61 | 0.73 | 0.92 |
Return on Equity (ROE) | -24.41% | -29.15% | -26.80% | -51.55% | -36.44% | -26.69% |
Return on Assets (ROA) | -1.02% | -1.44% | -1.46% | -3.57% | -3.84% | 0.73% |
Return on Invested Capital (ROIC) | -2.34% | -3.67% | -3.75% | -8.83% | -9.05% | 1.74% |
Return on Capital Employed (ROCE) | -5.00% | -7.60% | -8.10% | -19.50% | -19.40% | 2.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -18.46% | -18.54% | -16.31% | -29.84% | -23.77% | -38.20% |
FCF Yield | -4.32% | 14.87% | 41.04% | 16.99% | 13.38% | -5.52% |
Buyback Yield / Dilution | -23.78% | -6.00% | - | -0.12% | -0.22% | -6.01% |
Total Shareholder Return | -23.78% | -6.00% | - | -0.12% | -0.22% | -6.01% |